Glossary Of Biotechnology And Agrobiotechnology Terms 5Th Edition at Meripustak

Glossary Of Biotechnology And Agrobiotechnology Terms 5Th Edition

Books from same Author: Kimball Nill

Books from same Publisher: Taylor and Francis

Related Category: Author List / Publisher List


  • Retail Price: ₹ 25091/- [ 11.00% off ]

    Seller Price: ₹ 22331

Sold By: MeriPustak      Click for Bulk Order

Offer 1: Get ₹ 111 extra discount on minimum ₹ 500 [Use Code: Bharat]

Offer 2: Get 11.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 11.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available



Click for International Orders
  • Provide Fastest Delivery

  • 100% Original Guaranteed
  • General Information  
    Author(s)Kimball Nill
    PublisherTaylor and Francis
    Edition5th Edition
    ISBN9781498758208
    Pages414
    BindingHardbound
    LanguageEnglish
    Publish YearJuly 2016

    Description

    Taylor and Francis Glossary Of Biotechnology And Agrobiotechnology Terms 5Th Edition by Kimball Nill

    The 5th edition of Glossary of Biotechnology and Agrobiotechnology Terms will be a significant expansion of the previous 4th edition. In the past decade, many new terms have been introduced due to the appearance and application of new crop plant breeding methods as well as technical advances in genetics, molecular biology, cell biology and agricultural research. The terms associated with important new technologies have been added to this new edition including terms related to Zinc Finger Proteins, Transcription Activator-Like Effectors (TALEs), TALE Nucleases, Genome Editing, CRISPR/Cas 9 Gene-editing Systems, Oligonucleortide-mediated Mutagenesis, and RNA Interference, as well as hundreds of others. The 5th edition, like previous editions, will be useful for regulators of agricultural biotechnology around the world, customers, biotech patent officials, venture capitalists, and agbiotech company executives, as well as biopharmaceutical industries and academics.